Barito Pacific Valuation

Is OB8 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OB8 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OB8 (€0.04) is trading below our estimate of fair value (€0.08)

Significantly Below Fair Value: OB8 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for OB8?

Key metric: As OB8 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for OB8. This is calculated by dividing OB8's market cap by their current revenue.
What is OB8's PS Ratio?
PS Ratio2.3x
SalesUS$2.33b
Market CapUS$5.26b

Price to Sales Ratio vs Peers

How does OB8's PS Ratio compare to its peers?

The above table shows the PS ratio for OB8 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1x
FPE3 Fuchs
1.6x3.7%€4.9b
SIM0 SIMONA
0.6xn/a€345.0m
WCH Wacker Chemie
0.6x5.2%€3.5b
2NF Syensqo
1.1x4.2%€7.4b
OB8 Barito Pacific
2.3x11.4%€83.4t

Price-To-Sales vs Peers: OB8 is expensive based on its Price-To-Sales Ratio (2.3x) compared to the peer average (1x).


Price to Sales Ratio vs Industry

How does OB8's PS Ratio compare vs other companies in the European Chemicals Industry?

27 CompaniesPrice / SalesEstimated GrowthMarket Cap
OB8 2.3xIndustry Avg. 1.0xNo. of Companies30PS01.22.43.64.86+
27 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: OB8 is expensive based on its Price-To-Sales Ratio (2.3x) compared to the European Chemicals industry average (1x).


Price to Sales Ratio vs Fair Ratio

What is OB8's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OB8 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.3x
Fair PS Ratio1.4x

Price-To-Sales vs Fair Ratio: OB8 is expensive based on its Price-To-Sales Ratio (2.3x) compared to the estimated Fair Price-To-Sales Ratio (1.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OB8 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.044
€0.05
+12.4%
4.2%€0.052€0.048n/a2
Nov ’25€0.048
€0.049
+1.8%
4.2%€0.051€0.047n/a2
Oct ’25€0.053
€0.049
-7.8%
4.2%€0.051€0.047n/a2
Sep ’25€0.057
€0.049
-13.5%
4.2%€0.051€0.047n/a2
Aug ’25€0.053
€0.048
-10.4%
5.2%€0.05€0.045n/a2
Jul ’25€0.052
€0.049
-6.0%
5.3%€0.051€0.046n/a2
Jun ’25€0.051
€0.049
-4.0%
5.3%€0.051€0.046n/a2
May ’25€0.048
€0.064
+32.3%
32.3%€0.093€0.047n/a3
Apr ’25€0.046
€0.064
+39.5%
32.3%€0.093€0.047n/a3
Mar ’25€0.048
€0.069
+44.2%
28.0%€0.094€0.048n/a3
Feb ’25€0.05
€0.069
+38.4%
28.0%€0.094€0.048n/a3
Jan ’25€0.064
€0.069
+8.1%
28.0%€0.094€0.048n/a3
Dec ’24€0.046
€0.069
+48.8%
28.0%€0.094€0.048n/a3
Nov ’24€0.076
€0.073
-4.1%
33.1%€0.097€0.049€0.0482
Oct ’24€0.092
€0.073
-21.2%
33.1%€0.097€0.049€0.0532
May ’24€0.037
€0.057
+53.8%
4.3%€0.059€0.054€0.0482
Apr ’24€0.036
€0.057
+58.1%
4.3%€0.059€0.054€0.0462
Mar ’24€0.04
€0.057
+42.3%
4.3%€0.059€0.054€0.0482
Feb ’24€0.04
€0.057
+42.3%
4.3%€0.059€0.054€0.052
Jan ’24€0.031
€0.057
+83.6%
4.3%€0.059€0.054€0.0642
Dec ’23€0.04
€0.062
+56.6%
10.3%€0.071€0.055€0.0463
Nov ’23€0.042
€0.063
+51.0%
14.9%€0.076€0.05€0.0764

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies